This month, the House Energy and Commerce Committee launched an investigation into an obscure federal drug subsidy program known as “Medicaid 340B.” That’s good news for patients and taxpayers because 340B is out of control — and driving up health care costs for American families. Created in 1992 to help low-income and uninsured patients obtain […]
